Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
weight loss
Biotech
Viking sails oral weight loss drug to ph 2 after clinical win
Novo Nordisk may be racing to get an oral successor to its Wegovy weight loss sensation through clinical trials, but Viking is sailing up close behind.
James Waldron
Mar 26, 2024 10:04am
Another win for Novo in obesity as early oral med beats Wegovy
Mar 7, 2024 9:27am
Vivani's exenatide implant boosts weight loss as well as Wegovy
Mar 1, 2024 10:00am
NodThera's NLRP3 inhibitor nearly matches Wegovy for weight loss
Feb 21, 2024 8:30am
Novo Nordisk advances obesity pill as R&D spend skyrockets 35%
Jan 31, 2024 9:44am
Fractyl sets out $99M IPO ambitions after busy week for biotechs
Jan 29, 2024 9:31am